| Lastest Insider Transactions Of UroGen Pharma Ltd. ( URGN ) | |||||||||
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | 2026-09-07 | Sell | 871 | 42.92 | 37,383 | 2026-09-09 14:37:16 |
| URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | 2026-09-07 | Option Exercise | 1,667 | 0.00 | 0 | 2026-09-09 14:37:16 |
| URGN | UroGen Pharma Ltd. | Smith Jason Drew | General Counsel | 2026-09-07 | Sell | 1,519 | 42.54 | 64,618 | 2026-09-09 14:35:46 |
| URGN | UroGen Pharma Ltd. | Smith Jason Drew | General Counsel | 2026-09-07 | Option Exercise | 3,334 | 0.00 | 0 | 2026-09-09 14:35:46 |
| URGN | UroGen Pharma Ltd. | Robinson James A. Jr. | Directior | 2026-08-26 | Option Exercise | 2,000 | 0.00 | 0 | 2026-08-28 16:01:41 |
| URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | 2026-08-20 | Sell | 60,677 | 47.05 | 2,854,853 | 2026-08-24 17:03:17 |
| URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | 2026-07-09 | Sell | 10,000 | 40.00 | 400,000 | 2026-07-10 14:17:40 |
| URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | 2026-06-22 | Sell | 10,000 | 35.01 | 350,100 | 2026-06-24 10:22:49 |
| URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | 2026-06-08 | Sell | 5,222 | 27.30 | 142,561 | 2026-06-09 13:59:59 |
| URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | 2026-06-08 | Option Exercise | 10,000 | 0.00 | 0 | 2026-06-09 13:59:59 |
| URGN | UroGen Pharma Ltd. | Robinson James A. Jr. | Directior | 2026-05-26 | Option Exercise | 2,000 | 0.00 | 0 | 2026-05-27 08:04:51 |
| URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | 2026-05-08 | Sell | 10,000 | 30.00 | 300,000 | 2026-05-11 15:54:04 |
| URGN | UroGen Pharma Ltd. | Robinson James A. Jr. | Directior | 2026-02-26 | Option Exercise | 2,000 | 0.00 | 0 | 2026-02-27 16:44:12 |
| URGN | UroGen Pharma Ltd. | Smith Jason Drew | General Counsel | 2026-01-31 | Sell | 7,479 | 19.69 | 147,262 | 2026-02-11 14:54:58 |
| URGN | UroGen Pharma Ltd. | Smith Jason Drew | General Counsel | 2026-01-31 | Option Exercise | 15,500 | 0.00 | 0 | 2026-02-11 14:54:58 |
| URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | 2026-02-03 | Sell | 7,373 | 19.69 | 145,174 | 2026-02-04 19:37:34 |
| URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | 2026-01-31 | Option Exercise | 13,333 | 0.00 | 0 | 2026-02-03 17:18:26 |
| URGN | UroGen Pharma Ltd. | Holden Stuart | Directior | 2025-11-26 | Option Exercise | 2,000 | 0.00 | 0 | 2025-12-01 17:17:44 |
| URGN | UroGen Pharma Ltd. | BUTITTA CYNTHIA M | Directior | 2025-11-26 | Option Exercise | 2,000 | 0.00 | 0 | 2025-12-01 16:52:32 |
| URGN | UroGen Pharma Ltd. | Robinson James A. Jr. | Directior | 2025-11-26 | Option Exercise | 2,000 | 0.00 | 0 | 2025-12-01 16:47:46 |
| URGN | UroGen Pharma Ltd. | WEN LEANA | Directior | 2025-11-26 | Option Exercise | 2,000 | 0.00 | 0 | 2025-12-01 16:46:19 |
| URGN | UroGen Pharma Ltd. | Wildman Daniel George | Directior | 2025-11-26 | Option Exercise | 2,000 | 0.00 | 0 | 2025-12-01 16:44:50 |
| URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | 2025-11-19 | Sell | 10,000 | 25.00 | 250,000 | 2025-11-20 13:42:12 |
| URGN | UroGen Pharma Ltd. | Degnan Chris | Chief Financial Officer | 2025-10-08 | Sell | 2,203 | 16.85 | 37,121 | 2025-10-09 13:37:33 |
| URGN | UroGen Pharma Ltd. | Degnan Chris | Chief Financial Officer | 2025-10-08 | Option Exercise | 4,483 | 0.00 | 0 | 2025-10-09 13:37:33 |
| URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | 2025-09-07 | Sell | 871 | 19.11 | 16,645 | 2025-09-09 18:37:09 |
| URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | 2025-09-07 | Option Exercise | 1,667 | 0.00 | 0 | 2025-09-09 18:37:09 |
| URGN | UroGen Pharma Ltd. | Smith Jason Drew | General Counsel | 2025-09-07 | Sell | 1,520 | 19.11 | 29,047 | 2025-09-09 18:32:09 |
| URGN | UroGen Pharma Ltd. | Smith Jason Drew | General Counsel | 2025-09-07 | Option Exercise | 3,333 | 0.00 | 0 | 2025-09-09 18:32:09 |
| URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | 2025-08-11 | Sell | 10,000 | 17.69 | 176,900 | 2025-08-13 09:58:14 |
| URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | 2025-08-11 | Sell | 10,000 | 17.69 | 176,900 | 2025-08-13 09:58:14 |
| URGN | UroGen Pharma Ltd. | Smith Jason Drew | General Counsel | 2025-07-28 | Sell | 7,522 | 19.14 | 143,971 | 2025-07-30 16:03:45 |
| URGN | UroGen Pharma Ltd. | Smith Jason Drew | General Counsel | 2025-07-28 | Option Exercise | 16,500 | 0.00 | 0 | 2025-07-30 16:03:45 |
| URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | 2025-07-28 | Sell | 5,149 | 19.14 | 98,552 | 2025-07-30 16:02:05 |
| URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | 2025-07-28 | Option Exercise | 10,000 | 0.00 | 0 | 2025-07-30 16:02:05 |
| URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | 2025-06-08 | Sell | 5,162 | 7.37 | 38,044 | 2025-06-11 09:14:14 |
| URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | 2025-06-08 | Option Exercise | 10,000 | 0.00 | 0 | 2025-06-11 09:14:14 |
| URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | 2025-01-31 | Sell | 4,551 | 11.14 | 50,698 | 2025-02-04 11:53:22 |
| URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | 2025-01-31 | Option Exercise | 8,000 | 0.00 | 0 | 2025-02-04 11:53:22 |
| URGN | UroGen Pharma Ltd. | Smith Jason Drew | General Counsel | 2025-01-31 | Sell | 7,379 | 11.14 | 82,202 | 2025-02-04 11:51:51 |
| URGN | UroGen Pharma Ltd. | Smith Jason Drew | General Counsel | 2025-01-31 | Option Exercise | 14,667 | 0.00 | 0 | 2025-02-04 11:51:51 |
| URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | 2024-09-09 | Sell | 859 | 13.08 | 11,236 | 2024-09-12 13:54:09 |
| URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | 2024-09-09 | Option Exercise | 1,666 | 0.00 | 0 | 2024-09-12 13:54:09 |
| URGN | UroGen Pharma Ltd. | Smith Jason Drew | General Counsel | 2024-09-09 | Sell | 1,521 | 13.08 | 19,895 | 2024-09-12 13:51:58 |
| URGN | UroGen Pharma Ltd. | Smith Jason Drew | General Counsel | 2024-09-09 | Option Exercise | 3,333 | 0.00 | 0 | 2024-09-12 13:51:58 |
| URGN | UroGen Pharma Ltd. | Kim Dong | Chief Financial Officer | 2024-09-09 | Option Exercise | 2,500 | 0.00 | 0 | 2024-09-12 13:50:15 |
| URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | 2024-06-10 | Sell | 5,153 | 13.08 | 67,401 | 2024-06-11 13:15:23 |
| URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | 2024-06-10 | Option Exercise | 10,000 | 0.00 | 0 | 2024-06-11 13:15:23 |
| URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | 2024-03-18 | Sell | 12,000 | 14.05 | 168,600 | 2024-03-20 16:38:32 |
| URGN | UroGen Pharma Ltd. | Kim Dong | Chief Financial Officer | 2024-01-31 | Option Exercise | 3,333 | 0.00 | 0 | 2024-02-12 17:47:51 |
| URGN | UroGen Pharma Ltd. | Smith Jason Drew | General Counsel | 2024-01-31 | Sell | 4,993 | 15.78 | 78,790 | 2024-02-05 21:16:49 |
| URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | 2024-01-31 | Sell | 3,789 | 15.78 | 59,790 | 2024-02-05 21:15:14 |
| URGN | UroGen Pharma Ltd. | Smith Jason Drew | General Counsel | 2024-01-31 | Sell | 4,993 | 15.74 | 78,590 | 2024-02-02 19:12:24 |
| URGN | UroGen Pharma Ltd. | Smith Jason Drew | General Counsel | 2024-01-31 | Option Exercise | 10,000 | 0.00 | 0 | 2024-02-02 19:12:24 |
| URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | 2024-01-31 | Sell | 3,789 | 15.74 | 59,639 | 2024-02-02 19:07:36 |
| URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | 2024-01-31 | Option Exercise | 6,666 | 0.00 | 0 | 2024-02-02 19:07:36 |
| URGN | UroGen Pharma Ltd. | Kim Dong | Chief Financial Officer | 2024-01-31 | Option Exercise | 3,333 | 0.00 | 0 | 2024-02-02 19:05:51 |
| URGN | UroGen Pharma Ltd. | Smith Jason Drew | General Counsel | 2023-08-31 | Sell | 3,800 | 18.01 | 68,438 | 2023-09-05 16:28:18 |
| URGN | UroGen Pharma Ltd. | Smith Jason Drew | General Counsel | 2023-08-31 | Option Exercise | 8,334 | 0.00 | 0 | 2023-09-05 16:28:18 |
| URGN | UroGen Pharma Ltd. | Nussbaum Ran | Directior | 2022-06-06 | Option Exercise | 1,030 | 5.00 | 5,150 | 2023-02-28 12:29:13 |
| URGN | UroGen Pharma Ltd. | Nussbaum Ran | Directior | 2022-10-21 | Option Exercise | 47,999 | 5.94 | 285,114 | 2023-02-28 12:23:21 |
| URGN | UroGen Pharma Ltd. | Nussbaum Ran | Directior | 2022-06-16 | Option Exercise | 2,211 | 5.00 | 11,055 | 2023-02-28 12:21:59 |
| URGN | UroGen Pharma Ltd. | Barrett Elizabeth A. | Chief Executive Officer | 2023-01-31 | Option Exercise | 18,333 | 0.00 | 0 | 2023-02-02 15:40:58 |
| URGN | UroGen Pharma Ltd. | Smith Jason Drew | General Counsel | 2023-01-31 | Sell | 1,636 | 10.12 | 16,556 | 2023-02-02 13:04:04 |
| URGN | UroGen Pharma Ltd. | Smith Jason Drew | General Counsel | 2023-01-31 | Option Exercise | 3,333 | 0.00 | 0 | 2023-02-02 13:04:04 |
| URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | 2023-01-31 | Sell | 1,900 | 10.12 | 19,228 | 2023-02-02 13:02:20 |
| URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | 2023-01-31 | Option Exercise | 3,833 | 0.00 | 0 | 2023-02-02 13:02:20 |
| URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | 2023-01-20 | Option Exercise | 122,677 | 5.00 | 613,385 | 2023-01-23 19:10:39 |
